Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Gossypol

Base Information Edit
  • Chemical Name:Gossypol
  • CAS No.:20300-26-9
  • Deprecated CAS:732279-01-5,40112-23-0,123732-23-0,40112-23-0
  • Molecular Formula:C30H30 O8
  • Molecular Weight:518.60
  • Hs Code.:
  • European Community (EC) Number:636-899-7
  • NSC Number:728875,726190,624336,56817
  • UNII:8DY2X8LXW4,XNA7DR63CQ,KAV15B369O
  • DSSTox Substance ID:DTXSID5023110
  • Nikkaji Number:J126.059F,J2.536.108C,J2.536.109A,J858.559H,J21.393D
  • Wikipedia:Gossypol
  • Wikidata:Q411882
  • NCI Thesaurus Code:C529
  • Pharos Ligand ID:729J55RF7KWH
  • Metabolomics Workbench ID:28312
  • ChEMBL ID:CHEMBL51483
  • Mol file:20300-26-9.mol
Gossypol

Synonyms:Dipotassium Salt, Gossypol;Gossypol;Gossypol Dipotassium Salt;Gossypol Sodium Salt;Gossypol, (+)-Isomer;Gossypol, (+-)-Isomer;Gossypol, (-)-Isomer;Sodium Salt, Gossypol

Suppliers and Price of Gossypol
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • American Custom Chemicals Corporation
  • (S)-(+)-GOSSYPOL 95.00%
  • 5MG
  • $ 499.57
Total 3 raw suppliers
Chemical Property of Gossypol Edit
Chemical Property:
  • Melting Point:181-184° 
  • Refractive Index:1.4900 (estimate) 
  • Boiling Point:707.9 °C at 760 mmHg 
  • Flash Point:395.9 °C 
  • PSA:155.52000 
  • Density:1.403 g/cm3 
  • LogP:6.38220 
  • XLogP3:6.9
  • Hydrogen Bond Donor Count:6
  • Hydrogen Bond Acceptor Count:8
  • Rotatable Bond Count:5
  • Exact Mass:518.19406791
  • Heavy Atom Count:38
  • Complexity:780
Purity/Quality:

99% *data from raw suppliers

(S)-(+)-GOSSYPOL 95.00% *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:CC1=CC2=C(C(=C(C(=C2C(C)C)O)O)C=O)C(=C1C3=C(C4=C(C=C3C)C(=C(C(=C4C=O)O)O)C(C)C)O)O
  • Recent ClinicalTrials:Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Post RFQ for Price